These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36043326)

  • 1. A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study.
    Tarantini G; Fovino LN; Varbella F; Trabattoni D; Caramanno G; Trani C; De Cesare N; Esposito G; Montorfano M; Musto C; Picchi A; Sheiban I; Gasparetto V; Ribichini FL; Cardaioli F; Saccà S; Cerrato E; Napodano M; Martinato M; Azzolina D; Andò G; Mugnolo A; Caruso M; Rossini R; Passamonti E; Teles RC; Rigattieri S; Gregori D; Tamburino C; Burzotta F
    EuroIntervention; 2023 Feb; 18(13):e1108-e1119. PubMed ID: 36043326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
    Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
    JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year results from Onyx ONE clear in patients with high bleeding risk on one-month DAPT with and without intracoronary imaging.
    Toth GG; Kandzari DE; Kirtane AJ; Windecker S; Latib A; Kedhi E; Mehran R; Price MJ; Choi JW; Caputo R; Troquay R; Diderholm E; Singh S; Brar SS; Loussararian A; Chetcuti S; Tulli M; Stone GW; Lung TH; Mylotte D
    Cardiovasc Revasc Med; 2024 Jan; 58():60-67. PubMed ID: 37550123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guiding Intervention for Complex Coronary Lesions by Optical Coherence Tomography or Intravascular Ultrasound.
    Kang DY; Ahn JM; Yun SC; Hur SH; Cho YK; Lee CH; Hong SJ; Lim S; Kim SW; Won H; Oh JH; Choe JC; Hong YJ; Yoon YH; Kim H; Choi Y; Lee J; Yoon YW; Kim SJ; Bae JH; Park SJ; Park DW;
    J Am Coll Cardiol; 2024 Jan; 83(3):401-413. PubMed ID: 37879490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial.
    Chen SL; Zhang JJ; Han Y; Kan J; Chen L; Qiu C; Jiang T; Tao L; Zeng H; Li L; Xia Y; Gao C; Santoso T; Paiboon C; Wang Y; Kwan TW; Ye F; Tian N; Liu Z; Lin S; Lu C; Wen S; Hong L; Zhang Q; Sheiban I; Xu Y; Wang L; Rab TS; Li Z; Cheng G; Cui L; Leon MB; Stone GW
    J Am Coll Cardiol; 2017 Nov; 70(21):2605-2617. PubMed ID: 29096915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial.
    von Birgelen C; Zocca P; Buiten RA; Jessurun GAJ; Schotborgh CE; Roguin A; Danse PW; Benit E; Aminian A; van Houwelingen KG; Anthonio RL; Stoel MG; Somi S; Hartmann M; Linssen GCM; Doggen CJM; Kok MM
    Lancet; 2018 Oct; 392(10154):1235-1245. PubMed ID: 30253879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
    Ali ZA; Maehara A; Généreux P; Shlofmitz RA; Fabbiocchi F; Nazif TM; Guagliumi G; Meraj PM; Alfonso F; Samady H; Akasaka T; Carlson EB; Leesar MA; Matsumura M; Ozan MO; Mintz GS; Ben-Yehuda O; Stone GW;
    Lancet; 2016 Nov; 388(10060):2618-2628. PubMed ID: 27806900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial.
    Zocca P; Kok MM; Tandjung K; Danse PW; Jessurun GAJ; Hautvast RWM; van Houwelingen KG; Stoel MG; Schramm AR; Tjon Joe Gin RM; de Man FHAF; Hartmann M; Louwerenburg JHW; Linssen GCM; Löwik MM; Doggen CJM; von Birgelen C
    JACC Cardiovasc Interv; 2018 Mar; 11(5):462-469. PubMed ID: 29519378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.
    Cassese S; Kufner S; Xhepa E; Byrne RA; Kreutzer J; Ibrahim T; Tiroch K; Valgimigli M; Tölg R; Fusaro M; Schunkert H; Laugwitz KL; Mehilli J; Kastrati A
    Clin Res Cardiol; 2016 Jul; 105(7):575-84. PubMed ID: 26689707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of short-term clinical outcomes between Resolute Onyx zotarolimus-eluting stents and everolimus-eluting stent in patients with acute myocardial infarction: Results from the Korea Acute Myocardial infarction Registry (KAMIR).
    Kim Y; Oh SS; Jeong MH; Ahn Y; Kim JH; Hong YJ; Sim DS; Kim MC; Kim HS; Yun KH; Oh SK; Kim CJ; Cho MC
    Cardiol J; 2019; 26(5):469-476. PubMed ID: 29745969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel Diameter.
    Price MJ; Saito S; Shlofmitz RA; Spriggs DJ; Attubato M; McLaurin B; Popma Almonacid A; Brar S; Liu M; Moe E; Mehran R
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1381-1388. PubMed ID: 28728650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Thin-Strut Stents in Non-Left Main Bifurcation Coronary Lesions: A RAIN Subanalysis.
    De Filippo O; D'Ascenzo F; Angelini F; Franchin L; Cerrato E; Pennacchi M; Nuñez-Gil I; Wojakowski W; Imori Y; Trabattoni D; Huczek Z; Venuti G; Muscoli S; Iannaccone M; Montabone A; Marengo G; Rognoni A; Parma R; Figini F; Mitomo S; Boccuzzi G; Mattesini A; Quadri G; Wańha W; Smolka G; Rolfo C; Cortese B; Ryan N; Capodanno D; Chieffo A; di Mario C; Varbella F; Romeo F; Sheiban I; Escaned J; Helft G; De Ferrari GM
    J Invasive Cardiol; 2021 Nov; 33(11):E890-E899. PubMed ID: 34735352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided Percutaneous Coronary Intervention: The OCTIVUS Randomized Clinical Trial.
    Kang DY; Ahn JM; Yun SC; Hur SH; Cho YK; Lee CH; Hong SJ; Lim S; Kim SW; Won H; Oh JH; Choe JC; Hong YJ; Yoon YH; Kim H; Choi Y; Lee J; Yoon YW; Kim SJ; Bae JH; Park DW; Park SJ;
    Circulation; 2023 Oct; 148(16):1195-1206. PubMed ID: 37634092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial.
    Price MJ; Shlofmitz RA; Spriggs DJ; Haldis TA; Myers P; Popma Almonacid A; Maehara A; Dauler M; Peng Y; Mehran R
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):253-259. PubMed ID: 28940882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-Year Major Clinical Outcomes of Angiography-Guided Single Stenting Technique in Non-Complex Left Main Coronary Artery Diseases.
    Kim YH; Her AY; Rha SW; Choi BG; Shim M; Choi SY; Byun JK; Li H; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
    Int Heart J; 2017 Oct; 58(5):704-713. PubMed ID: 28966331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention).
    Taniwaki M; Stefanini GG; Silber S; Richardt G; Vranckx P; Serruys PW; Buszman PE; Kelbaek H; Windecker S;
    J Am Coll Cardiol; 2014 Apr; 63(16):1617-25. PubMed ID: 24530680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.